Reduction of Aβ in Down Syndrome cells by Targeting APP splicing with ASOs
Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β Production
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides.